Capital Fund Management (CFM)
CVAC

Capital Fund Management (CFM)’s CureVac CVAC Stock Holding History

Capital Fund Management (CFM)’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-233,371
Closed -$4.58M – 1468
2022
Q1 		$4.58M Buy
233,371
+132,757
+132% +$2.65M 0.04% 604
2021
Q4 		$3.45M Buy
+100,614
New +$4.05M 0.02% 784

Other funds holding CVAC

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Capital Fund Management (CFM)'s CVAC Position: Q2 2022 in Review

Capital Fund Management (CFM) sold out of CureVac (CVAC) in Q2 2022, closing a stake of 233,371 shares — an estimated $4.58M sold.

Capital Fund Management (CFM) first reported a position in CVAC in Q4 2021 and held it in 2 quarters. The position peaked at $4.58M in Q1 2022. 88 funds tracked by Wall St. Rank hold CVAC as of Q2 2022.

  • Capital Fund Management (CFM) reported no remaining CureVac position as of Q2 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 233,371 CureVac shares in Q2 2022, an estimated $4.58M.
  • Capital Fund Management (CFM) first reported a position in CureVac in Q4 2021 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s CureVac position peaked at $4.58M in Q1 2022.
  • 88 funds tracked by Wall St. Rank held CureVac as of Q2 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2022, filed 12 Aug 2022.